50.6 Million U.S. Adults Currently Use Tobacco Products

Findings from a Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report released today show that approximately 1 in 5 U.S. adults reported currently using a tobacco product in 2019, with about 80% of those adults reporting that they use combustible products such as cigarettes.

To assess recent national estimates of tobacco product use among U.S. adults 18 years or older, CDC analyzed data from the 2019 National Health Interview Survey. The survey measured use of five tobacco products: cigarettes, cigars (cigars, cigarillos, or filtered little cigars), pipes (regular pipes, water pipes, or hookahs), e-cigarettes, and smokeless tobacco (chewing tobacco, snuff, dip, snus, or dissolvable tobacco).

Currently, most tobacco-related death and disease in the United States are primarily caused by cigarettes and other combustible products. Yet, no form of tobacco product use is risk-free.

“The battle against tobacco use in this country is far from over,” said CDC Director Robert R. Redfield, MD. “Tobacco use remains the leading cause of preventable disease and death in the United States.”

Cigarettes still the most commonly used product; tobacco landscape continues to evolve

The study found that an estimated 50.6 million (20.8%) U.S. adults currently used a tobacco product in 2019. Most current tobacco product users (80.5%) reported using combustible products (cigarettes, cigars, or pipes), and cigarettes remained the most commonly used tobacco product (14.0%), followed by e-cigarettes (4.5%). E-cigarette use was highest among adults 18-24 years old (9.3%), with more than half (56.0%) of these young adults reporting that they had never smoked cigarettes.

U.S. adults reported using various non-cigarette tobacco products, with e-cigarettes being the second most commonly used tobacco product (4.5%), followed by cigars (3.6%), smokeless tobacco (2.4%), and pipes (1.0%). Among adults who currently use tobacco products, 18.6% reported using two or more tobacco products.

Disparities in tobacco product use

“Findings from this study show that disparities in tobacco product use continue to persist,” said Karen Hacker, MD, MPH, Director of CDC’s National Center for Chronic Disease Prevention and Health Promotion. “There is still much more that needs to be done to protect everyone from the harmful effects of tobacco use.”

By subpopulation groups, current use of any tobacco product in 2019 was highest among:

  • Males (26.2%)
  • Adults 25-44 years old (25.3%)
  • Non-Hispanic American Indian/Alaska Natives (29.3%)
  • Lesbian, gay, or bisexual adults (29.9%)
  • Adults 25 years old or older with a General Educational Development certificate (GED) (43.7%)
  • Adults with an annual household income less than $35,000 (27.0%)
  • Adults living in the Midwest (23.7%) or the South (22.9%)
  • Uninsured adults (30.2%) or those with Medicaid (30.0%)
  • Adults with a disability (26.9%)
  • Adults divorced, separated or widowed (23.5%), or adults who were single, never married, or not living with a partner (23.0%.)
  • Adults with mild (30.4%), moderate (34.2%), or severe generalized anxiety disorder (45.3%)

What more can be done?

The implementation of comprehensive, evidence-based, population-level interventions, in coordination with regulation of tobacco products, can reduce the burden of tobacco-related disease and death in the United States. These evidence-based, population-level strategies include implementation of tobacco price increases, comprehensive smoke-free policies, high-impact antitobacco media campaigns, and barrier-free cessation coverage. As part of a comprehensive approach, targeted interventions also are warranted to reach subpopulations with the greatest burden of use, which might vary by tobacco product type.

For support to quit tobacco product use, call 1-800-QUIT-NOW or visit for resources from CDC’s Tips From Former Smokers® campaign.

Related posts

CDC in 2016: Keeping America Safe From Health Threats New And Old – Press Release


CDC Highlights Significant Contributions in the Fight against Zika in 2016 – Press Release


CDC Telebriefing: Update on Acute Flaccid Myelitis (AFM) in the U.S.


Leave a Comment